[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Wilson's Disease Industry Research Report 2023

August 2023 | 85 pages | ID: WC03D93C1B6FEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

Highlights

The global Wilson's Disease market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wilson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease.

The Wilson's Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Wilson's Disease market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Wilson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Bausch Health
  • Teva
  • Endo International
  • Univar Solutions
  • MSN Laboratories
  • ANI Pharmaceuticals
  • APOTEX
  • Tsumura
  • Sinepharm
  • Taj Pharmaceutical
  • Kadmon Holdings
Product Type Insights

Global markets are presented by Wilson's Disease type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Wilson's Disease are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Wilson's Disease segment by Type
  • Trientine
  • Penicillamine
  • Others
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Wilson's Disease market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Wilson's Disease market.

Wilson's Disease Segment by Application
  • Hospital
  • Drugs Stores
  • Others
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Wilson's Disease market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wilson's Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Wilson's Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Wilson's Disease industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wilson's Disease.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Wilson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions
  • What factors will challenge the Product Name market growth?
  • Which end-use segment will expand at the fastest CAGR in the Product Name market?
  • Which are the emerging players in the Product Name market?
  • How concentrated is the Product Name market?
  • Which factors are positively contributing to the Product Name market growth?
  • Which are the novel product innovations in the Product Name market?
  • Which product segment will emerge as the most lucrative in the Product Name market?
  • Which factors are increasing the competition in the Product Name market?
  • Which are the strategic measures taken by the Product Name industry players?
  • Which region will witness inactive growth during the forecast period?
  • What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Wilson's Disease Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Wilson's Disease Revenue Market Share by Type (2018-2023)
Table 7. Global Wilson's Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Wilson's Disease Revenue Market Share by Type (2024-2029)
Table 9. Global Wilson's Disease Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Wilson's Disease Revenue Market Share by Application (2018-2023)
Table 11. Global Wilson's Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Wilson's Disease Revenue Market Share by Application (2024-2029)
Table 13. Global Wilson's Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Wilson's Disease Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Wilson's Disease Market Share by Region (2018-2023)
Table 16. Global Wilson's Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Wilson's Disease Market Share by Region (2024-2029)
Table 18. Wilson's Disease Market Trends
Table 19. Wilson's Disease Market Drivers
Table 20. Wilson's Disease Market Challenges
Table 21. Wilson's Disease Market Restraints
Table 22. Global Top Wilson's Disease Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Wilson's Disease Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Wilson's Disease Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Wilson's Disease, Headquarters and Area Served
Table 26. Global Wilson's Disease Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Wilson's Disease by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Wilson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Wilson's Disease Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Wilson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Wilson's Disease Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Wilson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Wilson's Disease Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Wilson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Wilson's Disease Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Wilson's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Wilson's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Wilson's Disease Market Size by Country (2024-2029) & (US$ Million)
Table 45. Bausch Health Company Detail
Table 46. Bausch Health Business Overview
Table 47. Bausch Health Wilson's Disease Product
Table 48. Bausch Health Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 49. Bausch Health Recent Development
Table 50. Teva Company Detail
Table 51. Teva Business Overview
Table 52. Teva Wilson's Disease Product
Table 53. Teva Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 54. Teva Recent Development
Table 55. Endo International Company Detail
Table 56. Endo International Business Overview
Table 57. Endo International Wilson's Disease Product
Table 58. Endo International Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 59. Endo International Recent Development
Table 60. Univar Solutions Company Detail
Table 61. Univar Solutions Business Overview
Table 62. Univar Solutions Wilson's Disease Product
Table 63. Univar Solutions Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 64. Univar Solutions Recent Development
Table 65. MSN Laboratories Company Detail
Table 66. MSN Laboratories Business Overview
Table 67. MSN Laboratories Wilson's Disease Product
Table 68. MSN Laboratories Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 69. MSN Laboratories Recent Development
Table 70. ANI Pharmaceuticals Company Detail
Table 71. ANI Pharmaceuticals Business Overview
Table 72. ANI Pharmaceuticals Wilson's Disease Product
Table 73. ANI Pharmaceuticals Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 74. ANI Pharmaceuticals Recent Development
Table 75. APOTEX Company Detail
Table 76. APOTEX Business Overview
Table 77. APOTEX Wilson's Disease Product
Table 78. APOTEX Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 79. APOTEX Recent Development
Table 80. Tsumura Company Detail
Table 81. Tsumura Business Overview
Table 82. Tsumura Wilson's Disease Product
Table 83. Tsumura Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 84. Tsumura Recent Development
Table 85. Sinepharm Company Detail
Table 86. Sinepharm Business Overview
Table 87. Sinepharm Wilson's Disease Product
Table 88. Sinepharm Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 89. Sinepharm Recent Development
Table 90. Taj Pharmaceutical Company Detail
Table 91. Taj Pharmaceutical Business Overview
Table 92. Taj Pharmaceutical Wilson's Disease Product
Table 93. Taj Pharmaceutical Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 94. Taj Pharmaceutical Recent Development
Table 95. Kadmon Holdings Company Detail
Table 96. Kadmon Holdings Business Overview
Table 97. Kadmon Holdings Wilson's DiseaseProduct
Table 98. Kadmon Holdings Revenue in Wilson's Disease Business (2017-2022) & (US$ Million)
Table 99. Kadmon Holdings Recent Development
Table 100. Bausch Health Company Information
Table 101. Bausch Health Business Overview
Table 102. Bausch Health Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 103. Bausch Health Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 104. Bausch Health Recent Development
Table 105. Teva Company Information
Table 106. Teva Business Overview
Table 107. Teva Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 108. Teva Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 109. Teva Recent Development
Table 110. Endo International Company Information
Table 111. Endo International Business Overview
Table 112. Endo International Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 113. Endo International Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 114. Endo International Recent Development
Table 115. Univar Solutions Company Information
Table 116. Univar Solutions Business Overview
Table 117. Univar Solutions Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 118. Univar Solutions Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 119. Univar Solutions Recent Development
Table 120. MSN Laboratories Company Information
Table 121. MSN Laboratories Business Overview
Table 122. MSN Laboratories Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 123. MSN Laboratories Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 124. MSN Laboratories Recent Development
Table 125. ANI Pharmaceuticals Company Information
Table 126. ANI Pharmaceuticals Business Overview
Table 127. ANI Pharmaceuticals Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 128. ANI Pharmaceuticals Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 129. ANI Pharmaceuticals Recent Development
Table 130. APOTEX Company Information
Table 131. APOTEX Business Overview
Table 132. APOTEX Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 133. APOTEX Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 134. APOTEX Recent Development
Table 135. Tsumura Company Information
Table 136. Tsumura Business Overview
Table 137. Tsumura Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 138. Tsumura Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 139. Tsumura Recent Development
Table 140. Sinepharm Company Information
Table 141. Sinepharm Business Overview
Table 142. Sinepharm Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 143. Sinepharm Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 144. Sinepharm Recent Development
Table 145. Taj Pharmaceutical Company Information
Table 146. Taj Pharmaceutical Business Overview
Table 147. Taj Pharmaceutical Wilson's Disease Revenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 148. Taj Pharmaceutical Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 149. Taj Pharmaceutical Recent Development
Table 150. Kadmon Holdings Company Information
Table 151. Kadmon Holdings Business Overview
Table 152. Kadmon Holdings Wilson's DiseaseRevenue in Wilson's Disease Business (2018-2023) & (US$ Million)
Table 153. Kadmon Holdings Revenue in Wilson's Disease Business (2018-2023) & (US$ Million) Portfolio
Table 154. Kadmon Holdings Recent Development
Table 155. Authors 12. List of This Report

LIST OF FIGURES

Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Wilson's Disease Product Picture
Figure 5. Global Wilson's Disease Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Wilson's Disease Market Share by Type: 2022 VS 2029
Figure 7. Trientine Product Picture
Figure 8. Penicillamine Product Picture
Figure 9. Others Product Picture
Figure 10. Global Wilson's Disease Market Size by Application (2023-2029) & (US$ Million)
Figure 11. Global Wilson's Disease Market Share by Application: 2022 VS 2029
Figure 12. Hospital Product Picture
Figure 13. Drugs Stores Product Picture
Figure 14. Others Product Picture
Figure 15. Global Wilson's Disease Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Wilson's Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Wilson's Disease Market Share by Region: 2022 VS 2029
Figure 18. Global Wilson's Disease Market Share by Players in 2022
Figure 19. Global Wilson's Disease Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Wilson's Disease Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Wilson's Disease Market Share by Country (2018-2029)
Figure 24. United States Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Wilson's Disease Market Share by Country (2018-2029)
Figure 28. Germany Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Wilson's Disease Market Share by Country (2018-2029)
Figure 36. China Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Wilson's Disease Market Share by Country (2018-2029)
Figure 44. Mexico Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Wilson's Disease Market Share by Country (2018-2029)
Figure 48. Turkey Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Wilson's Disease Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Bausch Health Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 52. Teva Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 53. Endo International Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 54. Univar Solutions Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 55. MSN Laboratories Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 56. ANI Pharmaceuticals Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 57. APOTEX Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 58. Tsumura Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 59. Sinepharm Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 60. Taj Pharmaceutical Revenue Growth Rate in Wilson's Disease Business (2018-2023)
Figure 61. Kadmon Holdings Revenue Growth Rate in Wilson's Disease Business (2018-2023)


More Publications